Stockscreener 앱 받기
6.81
3.50%
0.23
시간 외 거래:
6.75
-0.06
-0.88%
Longeveron Inc 주식(LGVN)의 최신 뉴스
LGVN Stock Slips After Hours As FDA Flags Concerns On Rare Heart Defect Trial Design - Stocktwits
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study - Stocktwits
Longeveron Stock Price Forecast. Should You Buy LGVN? - StockInvest.us
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming DeadlineLGVN - TMX Newsfile
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference - manilatimes.net
A biotech presentation is set for New York on Sept. 14 - Stock Titan
Longeveron | 4: Statement of changes in beneficial ownership of securities - Moomoo
Longeveron (LGVN) Gains 2.68% as Shares Hold Above Key Support at $6.55Breakout Confirmation - vinanet.vn
Longeveron To Carry Out 1-for-10 Reverse Stock Split On August 27th, 2026 - Moomoo
Longeveron Announces 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance - Intellectia AI
Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday - Sahm
Longeveron Announces 1-for-10 Reverse Stock Split - The National Law Review
Longeveron Executes 1-for-10 Reverse Stock Split - TipRanks
Longeveron Inc. Earnings Call: Trials, Cash and Risk - TipRanks
Longeveron (NASDAQ: LGVN) insider logs new stock trades - Stock Titan
Longeveron (LGVN) grants director 36,000 stock units - Stock Titan
Longeveron (NASDAQ: LGVN) insider reports new stock dealings - Stock Titan
Longeveron (LGVN) insider logs new stock transactions in company shares - Stock Titan
Longeveron (LGVN) Q2 2026 Earnings Call Transcript - AOL.ca
Longeveron (LGVN) Earnings Reading: Profit Per Share Falls Below Its Benchmark at the Close; After Results: The Stock Gains 4.46% in the Current UpdateEarnings Sentiment Score - dars.gov.et
Longeveron appoints Nirav Jhaveri as chief financial officer - Investing.com Nigeria
Longeveron Appoints Nirav Jhaveri as CFO Ahead of September Trial Data - Minichart
symbol__ Stock Quote Price and Forecast - CNN
Longeveron CFO Marie Washburn to switch roles, Nirav Jhaveri to succeed - TipRanks
Longeveron Appoints New Chief Financial Officer Jhaveri - TipRanks
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer - The Manila Times
Longeveron Appoints Nirav Jhaveri As CFO - marketscreener.com
Longeveron appoints Nirav Jhaveri as chief financial officer By Investing.com - Investing.com India
Longeveron Inc. Appoints Nirav Jhaveri as Chief Financial Officer - Quiver Quantitative
Marie Washburn Net Worth (2026) - GuruFocus
Longeveron reports Q2 EPS (19c) vs. (33c) last year - TipRanks
$Longeveron (LGVN.US)$ - Moomoo
Longeveron Inc. (LGVN) investors disclose 9% beneficial stake through warrant holdings - Stock Titan
Longeveron LLC earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update - BioSpace
Longeveron Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Longeveron Q2 EPS $(0.19) Misses Estimate, Sales Fall 9% - scanx.trade
LGVN: Q2 2026 net loss rose to $6.1M as HLHS trial data and XPRIZE finalist status drive near-term focus - TradingView
Earnings call transcript: Longeveron misses Q2 2026 estimates as cash runs tight - Investing.com
Longeveron Inc. (LGVN) Q2 FY2026 earnings call transcript - Yahoo Finance
Longeveron Reports $6.1 Million Q2 Net Loss Ahead Of ELPIS II Data - Quiver Quantitative
Longeveron Q2 net loss widens on higher legal, clinical trial costs - TradingView
LGVN: Q2 2026 net loss rose 22% as clinical and legal expenses increased ahead of key trial results - TradingView
BRIEF-Longeveron Q2 EPS USD -0.19 - TradingView
Longeveron Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Longeveron (LGVN) Rises 7.92% to $0.75, Approaches Key Resistance at $0.79Dividend Arbitrage - dars.gov.et
Earnings To Watch: Longeveron Inc (LGVN) Q2 2026 -- GF Value Sees 58% Downside - Yahoo Finance
Longeveron Selected as XPRIZE Healthspan Milestone 2 Awardee for Laromestrocel Clinical Trial Results - Quiver Quantitative
Longeveron Named a Finalist Team and Will Receive a - GlobeNewswire
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition - manilatimes.net
Longeveron Inc. (LGVN): Millennium group discloses 5.2% Class A equity stake - Stock Titan
Longeveron Restores Nasdaq Compliance with New Audit Committee - TipRanks
LONGEVERON INC. (LGVN) SHAREHOLDER LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against the Longeveron Inc. - TMX Newsfile
Earnings Preview: Longeveron to Report Financial Results Post-market on August 12 - Moomoo
LGVN Q2'26 Earnings: revenue estimate is 326.00K USD - TradingView
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026 - The Manila Times
Longeveron will share second-quarter results after markets close Aug. 12 - Stock Titan
0.86%
0.31%
자본화:
|
볼륨(24시간):